封面
市场调查报告书
商品编码
1567215

细胞凋亡市场:按应用、按方式、按最终用户、按地区

Apoptosis Market, By Application, By Modality, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球细胞凋亡市场规模为38.1亿美元,预计到2031年将达到56.5亿美元,2024年至2031年的复合年增长率为5.8%。

报告范围 报告详情
基准年 2023年 2024年市场规模 38.1亿美元
实际资料 2019年至2023年 预测期 从2024年到2031年
预测 2024-2031 年复合年增长率: 5.80% 2031年价值预测 56.5亿美元
图:2024 年按地区分類的细胞凋亡市场占有率(%)
细胞凋亡市场-IMG1

细胞凋亡,通常称为程序性细胞死亡,是活生物体中的一种自然过程,以受控方式去除不需要或受损的细胞。细胞凋亡失调可导致癌症、自体免疫疾病和神经退化性疾病等病理状况。因此,研究和开发调节细胞凋亡的新标靶治疗疗法来治疗此类疾病正在促进该市场的成长。细胞凋亡分子机制的阐明和新型途径抑制剂的开发取得的进展扩大了它们的应用,并增加了全世界对细胞凋亡调节药物的需求。

市场动态:

癌症和其他细胞凋亡相关疾病盛行率的上升、製药公司研发投资的增加以及美国食品和药物管理局对新型靶向细胞凋亡调节药物的核准增加预计将在预测期内推动全球细胞凋亡市场的发展。据世界卫生组织称,未来 20 年癌症负担预计将增加 70%。然而,与药物开拓和临床试验相关的高成本可能会阻碍市场成长。从积极的一面来看,亚太和拉丁美洲等新兴市场由于医疗成本不断上升以及对优质医疗保健的需求,为市场参与者提供了利润丰厚的机会。此外,对联合治疗和管道药物的持续探索将在未来几年继续产生新的前景。

本研究的主要特点

本报告详细分析了全球细胞凋亡市场,并提供了以2023年为基准年的预测期(2024-2031)的市场规模和年复合成长率(CAGR%)。

它还揭示了各个细分市场的潜在商机,并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

它根据公司亮点、产品系列、主要亮点、业绩和策略等参数,介绍了全球细胞凋亡市场中的主要企业的概况。

主要企业包括雅培、罗氏、诺华、百时美施贵宝、默克和辉瑞。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球细胞凋亡市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球细胞凋亡市场的各种策略矩阵,将促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管场景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第 4 章全球细胞凋亡市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球细胞凋亡市场,依应用分类,2019-2031

  • 肿瘤学
  • 神经退化性疾病
  • 自体免疫疾病
  • 心血管疾病
  • 其他的

第六章 全球细胞凋亡市场,依模式,2019-2031

  • 细胞凋亡检测
  • 凋亡抗体
  • 细胞凋亡抑制剂和诱导剂

第 7 章 全球细胞凋亡市场,依最终使用者划分,2019-2031

  • 製药和生物技术公司
  • 学术研究所
  • 合约研究组织
  • 其他的

第八章全球细胞凋亡市场,按地区,2019-2031

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第9章 竞争格局

  • 公司简介
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories
    • GE Healthcare
    • Becton, Dickinson and Company(BD)
    • Promega Corporation
    • Sartorius AG
    • Abcam plc.
    • Biotium
    • Geno Technology
    • BioTek Instruments
    • Canvax
    • Abnova
    • Creative Bioarray
    • PerkinElmer
    • Danaher Corporation
    • Bio-Techne
    • GeneCopoeia, Inc.
    • Takara Bio Inc.
    • Bioss Antibodies

第10章分析师建议

第十一章调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI7358

The Global Apoptosis Market is estimated to be valued at USD 3.81 Billion in 2024 and is expected to reach USD 5.65 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 3.81 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 5.80% 2031 Value Projection: US$ 5.65 Bn
Figure. Apoptosis Market Share (%), By Region, 2024
Apoptosis Market - IMG1

Apoptosis, commonly known as programmed cell death, is a natural process in living organisms to remove unnecessary or damaged cells in a controlled manner. Dysregulation of apoptosis can lead to pathogenic conditions like cancer, autoimmune disorders, and neurodegenerative diseases. Therefore, research and development of new targeted therapeutics to modulate apoptosis for treatment of such diseases is contributing to the growth of this market. Advancements in understanding the molecular mechanisms of apoptosis and development of novel pathway inhibitors are expanding the applications and driving the demand for apoptosis modulating drugs globally.

Market Dynamics:

Rise in prevalence of cancer and other apoptosis related disorders, increasing R&D investments by pharmaceutical companies, and growing USFDA approvals for novel targeted apoptosis modulating drugs are some of the major factors projected to propel the global apoptosis market during the forecast period. According to WHO, cancer burden is expected to grow by 70% in the next two decades. However, high costs associated with drug development and clinical trials may hamper market growth. On the positive side, emerging markets such as Asia Pacific and Latin America offer lucrative opportunities for market players due to growing healthcare expenditure and demand for quality care in these regions. Furthermore, ongoing research on combination therapies and pipeline drugs will continue creating new prospects over the coming years.

Key features of the study:

This report provides in-depth analysis of the global apoptosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global apoptosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbot, Roche, Novartis, Bristol-Myers Squibb, Merck, and Pfizer

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global apoptosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global apoptosis market.

Detailed Segmentation-

  • By Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Oncology
    • Neurodegenerative Diseases
    • Autoimmune Disorders
    • Cardiovascular Diseases
    • Others
  • By Modality Insights (Revenue, USD Bn, 2019 - 2031)
    • Apoptosis Assays
    • Apoptosis Antibodies
    • Apoptosis Inhibitors and Inducers
  • By End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Contract Research Organizations
    • Ohers
  • Regional Insights (Revenue, USD Bn 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories
    • GE Healthcare
    • Becton, Dickinson and Company (BD)
    • Promega Corporation
    • Sartorius AG
    • Abcam plc.
    • Biotium
    • Geno Technology
    • BioTek Instruments
    • Canvax
    • Abnova
    • Creative Bioarray
    • PerkinElmer
    • Danaher Corporation
    • Bio-Techne
    • GeneCopoeia, Inc.
    • Takara Bio Inc.
    • Bioss Antibodies

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By Modality
    • Market Snapshot, By End User
    • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Apoptosis Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Apoptosis Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Oncology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Neurodegenerative Diseases
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Autoimmune Disorders
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cardiovascular Diseases
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Apoptosis Market, By Modality, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Apoptosis Assays
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Apoptosis Antibodies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Apoptosis Inhibitors and Inducers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Apoptosis Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic and Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Apoptosis Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Merck KGaA
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific, Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bio-Rad Laboratories
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GE Healthcare
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Becton, Dickinson and Company (BD)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Promega Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sartorius AG
    • Abcam plc.
    • Biotium
    • Geno Technology
    • BioTek Instruments
    • Canvax
    • Abnova
    • Creative Bioarray
    • PerkinElmer
    • Danaher Corporation
    • Bio-Techne
    • GeneCopoeia, Inc.
    • Takara Bio Inc.
    • Bioss Antibodies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact